Free press releases distribution network?

More news: Health/Surgery
Agency / Source: Espère Healthcare Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



British National Health Service Makes Dermasilk® Therapeutic Clothing Available On Prescription - DermaSilk® Therapeutic Clothing has been approved for inclusion on the UK Drug Tariff. These undergarments have been clinically proven to be more effective than cotton garments in alleviating the
British National Health Service Makes Dermasilk® Therapeutic Clothing Available On Prescription

 

PRZOOM - /newswire/ - Bedford, Bedfordshire, United Kingdom, 2007/07/10 - DermaSilk® Therapeutic Clothing has been approved for inclusion on the UK Drug Tariff. These undergarments have been clinically proven to be more effective than cotton garments in alleviating the "itch/scratch" associated with eczema and dermatitis.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

From August 1st 2007, part of the DermaSilk® Therapeutic Clothing range will be available for dermatologists, nurses and doctors in the United Kingdom to prescribe in cases of atopic dermatitis and eczema. The PPA (Prescription Pricing Authority) has approved the children’s range, plus the tubular sleeves and gloves for use by both children and adults, for inclusion on the Drug Tariff.

This exciting announcement was made at the BAD (British Association of Dermatology) Annual Meeting at the Birmingham International Conference Centre on July 10th. Espère Healthcare Ltd is the exclusive distributor for DermaSilk in the UK and Ireland, and is also responsible for marketing the products in the USA and Canada. Co-director Chris Steeples commented as follows, “These products have only been available in Britain since last September and they’ve already built up a very strong following. In fact, virtually every single dermatology nurse and community nurse that we’ve spoken to has been asking when they’ll be available on prescription! I’m delighted that the NHS has approved DermaSilk so quickly. These undergarments are very comfortable and children are happy to wear them. PPA approval means a lot to us, but it also means a lot for children with eczema and their families.”

The complete list of DermaSilk products approved by the PPA is as follows:

• Bodysuit with folding gloves (sizes from newborn up to 4 years)
• Infant leggings (sizes from newborn up to 4 years)
• Pyjamas (sizes from 3 years up to 12 years)
• Facial mask (sizes for infants and children up to age 10)
• Gloves (for children aged 4 upwards and adults)
• Tubular sleeves (one size fits both children and adults)

DermaSilk Therapeutic Clothing (dermasilk.co.uk) is registered in Europe as a Class 1 Medical Device, and published clinical trials have demonstrated its effectiveness in helping patients with skin disorders reduce the itching and scratching associated with eczema and contact dermatitis. DermaSilk® Therapeutic Clothing is available in the USA and Canada direct from Espère Healthcare Ltd in England.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Espère Healthcare Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


British National Health Service Makes Dermasilk® Therapeutic Clothing Available On Prescription

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Chris Steeples - Esperehealth.co.uk 
+44(0)78 1463 9204 chris[.]esperehealth.co.uk
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Espère Healthcare Ltd securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Espère Healthcare Ltd / Company Profile


Read Health/Surgery Most Recent Related Press Releases:

Global Hemoglobinopathy Market Worth US$ 788M by 2024 According to Persistence Market Research
Dentsu Announces its Corporate Venture Capital Fund Dentsu Ventures Investment in Grail
Xenex Receives Top Honors from Frost & Sullivan for LightStrike™ - the Only Pulsed Xenon UV Disinfection System in the Healthcare Market
Partners HealthCare and GE Healthcare Launch 10-year Collaboration to Integrate Artificial Intelligence into Every Aspect of the Patient Journey
US Acute Care Solutions Celebrates 2-Year Anniversary
GE Healthcare Receives FDA Indication Approval for Visipaque™ (iodixanol) Injection for use with Coronary CT Angiography
Telehealth Vendors Expand mHealth Portfolio to Conquer New Growth Opportunities Finds Frost & Sullivan
GE Healthcare Acquires Asymptote for Complete, Digitally-enabled Cryogenic Cold Chain Technology Supporting Safe Manufacture And Delivery Of Cellular
ANVISA Approval for EMCM Facilitates the Progress of Leader Biomedical Operations in Brazil
GE Healthcare Expands Digital Maternal-Infant Care Offerings with Acquisition of Monica Healthcare

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today